Search results for "PLASMA"

showing 10 items of 4043 documents

Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with pr…

2003

Abstract The potential use of autologous thrombocytic growth factors to accelerate bone regeneration requires improved methods of isolating platelet-rich plasma (PRP). In addition to discontinuous cell separation, a second method by which PRP is produced at the point-of-care has now become available. In this study, growth factor levels in PRP from these two sources were compared. Whole blood was drawn from 115 healthy donors (73 males, 42 females) aged 21 - 62 years (mean 36, SD 10). The PRP was separated by the blood bank (BB) using the discontinuous cell separation method or at the 'point-of-care' by the so-called 'buffy coat' method (analogous to the Curasan PRP Kit). Growth factor conte…

medicine.medical_specialtyPlatelet-derived growth factorGrowth factormedicine.medical_treatmentBuffy coatBiologychemistry.chemical_compoundInsulin-like growth factorEndocrinologychemistryPlatelet-rich plasmaInternal medicinemedicinePlateletOral SurgeryBone regenerationWhole bloodClinical Oral Implants Research
researchProduct

Haemorheological components in the pre-geriatric and geriatric age range in a randomly selected Western Sicily population sample (Casteldaccia study)

1993

{Received 24.8.1992; accepted 7.12.1992} On a randomly selected western Sicily population sample (Casteldac­ cia Study: 600 subjects; 300 males and 300 females) of an age range from 40 to 79 years, were determined: Haematocrit (Htc) , blood vi­ scosity, plasma viscosity, filterability of whole blood and fibrinogen. Par­ ticipation was 97%, being 582 subjects (M = 287, F = 295). All the parameters measured showed a progressive increase with age and si­ gnificant differences were found between male and female subjects: Htc and blood viscosity were higher in male subjects (p < 0.01), while plasma viscosity, whole blood filterability and fibrinogen were higher in female subjects (p < 0.05). In …

medicine.medical_specialtyPopulation samplePhysiologybusiness.industryBlood viscosityHematologyFibrinogenGastroenterologyCoronary heart diseaseSurgeryPhysiology (medical)Internal medicinemedicineRisk factorCardiology and Cardiovascular MedicinebusinessPlasma viscosityWhole bloodmedicine.drugClinical Hemorheology and Microcirculation
researchProduct

Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases

2018

The risk of cardiovascular (CV) events and mortality is significantly higher in patients with systemic rheumatic diseases than in the general population. Although CV involvement in such patients is highly heterogeneous and may affect various structures of the heart, it can now be diagnosed earlier and promptly treated. Various types of assessments are employed for the evaluation of CV risk such as transthoracic or transesophageal echocardiography, magnetic resonance imaging (MRI), and computed tomography (CT) to investigate valve abnormalities, pericardial disease, and ventricular wall motion defects. The diameter of coronary arteries can be assessed using invasive quantitative coronarograp…

medicine.medical_specialtyPopulationSpeckle tracking echocardiographyReview030204 cardiovascular system & hematologyendothelial dysfunction03 medical and health sciences0302 clinical medicinemedicine.arteryInternal medicineIntravascular ultrasoundmedicinesystemic rheumatic diseasesBrachial arteryeducationatherosclerosis; computed tomography; coronary artery diseases; endothelial dysfunction; plasma asymmetric dimethylarginine; systemic rheumatic diseases030203 arthritis & rheumatologyeducation.field_of_studylcsh:R5-920medicine.diagnostic_testbusiness.industryCoronary flow reserveMagnetic resonance imagingcomputed tomographyGeneral Medicineplasma asymmetric dimethylarginineCoronary arteriescoronary artery diseasesmedicine.anatomical_structurePositron emission tomographyCardiologyMedicineatherosclerosisbusinesslcsh:Medicine (General)Frontiers in Medicine
researchProduct

Strategies for managing Asherman's syndrome and endometrial atrophy: Since the classical experimental models to the new bioengineering approach

2021

Endometrial function is essential for embryo implantation and pregnancy, but managing endometrial thickness that is too thin to support pregnancy or an endometrium of compromised functionality due to intrauterine adhesions is an ongoing challenge in reproductive medicine. Here, we review current and emerging therapeutic and experimental options for endometrial regeneration with a focus on animal models used to study solutions for Asherman's syndrome and endometrial atrophy, which both involve a damaged endometrium. A review of existing literature was performed that confirmed the lack of consensus on endometrial therapeutic options, though promising new alternatives have emerged in recent ye…

medicine.medical_specialtyPregnancyPlatelet-Rich PlasmaRegeneration (biology)Reproductive medicineAsherman's syndromeGynatresiaCell BiologyBiologymedicine.diseaseBioinformaticsEndometriumENDOMETRIAL ATROPHYClinical trialDisease Models AnimalEndometriummedicine.anatomical_structureGeneticsmedicineAnimalsHumansFemaleStem cellStem Cell TransplantationDevelopmental BiologyMolecular Reproduction and Development
researchProduct

Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and…

2013

Objective To analyze whether assisted conceptions need adjustments in first-trimester Down syndrome screening and why modifications in screening markers occur. Design Eleven-year cohort retrospective analysis. Setting Maternal-fetal medicine unit. Patient(s) Two thousand eleven naturally conceived normal singleton pregnancies and 2,042 normal singleton pregnancies achieved with assisted conception: 350 by IUI and 1,692 with IVF (n = 328) or intracytoplasmic sperm injection (ICSI; n=1,364), using nondonor (n = 1,086) or donated ova (n = 606), with fresh (n = 1,432) or frozen (n = 260) embryos. Intervention(s) Comparison of ultrasound and biochemical markers of first-trimester Down syndrome s…

medicine.medical_specialtyPregnancy-associated plasma protein AReproductive Techniques Assistedmedicine.medical_treatmentDown-RegulationFertilization in VitroIntracytoplasmic sperm injectionEmbryo cryopreservationPredictive Value of TestsPregnancyPrenatal DiagnosismedicineHumansPregnancy-Associated Plasma Protein-AChorionic Gonadotropin beta Subunit HumanFalse Positive Reactionsreproductive and urinary physiologyInsemination ArtificialRetrospective StudiesGynecologyDown syndrome screeningAnalysis of VarianceChi-Square DistributionOocyte Donationbusiness.industrySingletonFree βhcgObstetrics and GynecologyPregnancy Trimester FirstReproductive MedicineCohortFemaleHormone therapyDown SyndromebusinessNuchal Translucency MeasurementBiomarkersFertility and sterility
researchProduct

Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura.

2021

Introduction Thrombotic thrombocytopenic purpura (TTP) is a life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ injury. TTP pathophysiology is based on a severe ADAMTS13 deficiency, and is a medical emergency with fatal outcome if appropriate treatment is not initiated promptly. Areas covered Authors will review the best options currently available to minimize mortality, prevent relapses, and obtain the best clinical response in patients with immune TTP (iTTP). Available bibliography about iTTP treatment has been searched in Library's MEDLINE/PubMed database from January 1990 until April 2021. Expert opinion The general…

medicine.medical_specialtyPurpura Thrombocytopenic IdiopathicThrombotic microangiopathyPlasma ExchangePurpura Thrombotic Thrombocytopenicbusiness.industrymedicine.medical_treatmentThrombotic thrombocytopenic purpuraADAMTS13 ProteinHematologyMicroangiopathic hemolytic anemiaDiseasemedicine.diseaseADAMTS13Targeted therapyPharmaceutical Preparationshemic and lymphatic diseasesmedicineHumansRituximabCaplacizumabIntensive care medicinebusinessRituximabmedicine.drugExpert review of hematology
researchProduct

Single Preoperative Oral Application of Ascorbic Acid Does Not Affect Postoperative Plasma Levels of Ascorbic Acid

2002

&lt;i&gt;Background and Aims:&lt;/i&gt; A decrease in ascorbic acid (AA) plasma concentration is well known during the postoperative period and postulated to be caused by increased radical scavenging activity in response to surgical trauma. This often affects postoperative patients and is associated with multiple organ failure. Therefore, substitution of AA could potentially decrease the risk of postoperative complications. This study examines the effect of preoperative oral administration of 1,000 mg AA on the postoperative AA plasma concentration. &lt;i&gt;Methods:&lt;/i&gt; 54 patients were randomly split into two groups; patients in group 1 received no AA preoperatively while group 2 re…

medicine.medical_specialtyRandomizationAntioxidantMultiple Organ Failuremedicine.medical_treatmentAdministration OralMedicine (miscellaneous)Ascorbic AcidGastroenterologyAntioxidantsPostoperative ComplicationsOral administrationInternal medicinePreoperative CareBlood plasmamedicineHumansOral applicationPostoperative PeriodAgedNutrition and DieteticsVitamin CChemistryPlasma levelsMiddle AgedAscorbic acidSurgical Procedures OperativeAnesthesiaAnnals of Nutrition and Metabolism
researchProduct

Pediatric non-red cell blood product transfusion practices: what's the evidence to guide transfusion of the ‘yellow’ blood products?

2020

Purpose of review Research studies pertaining to the management of pediatric non-red cell blood product transfusion is limited. Clinical practices vary within disciplines and regions. Anesthesiologists need evidence-based guidelines to make appropriate and safe decisions regarding transfusion of the 'yellow' blood products for pediatric patients. Recent findings This review outlines clinical indications for transfusion of fresh frozen plasma, cryoprecipitate, platelets, and fibrinogen concentrate in pediatrics. Recent studies of non-red blood cell transfusions in critical, but stable situations are highlighted. Recommendations to guide transfusion of the 'yellow' blood products in operative…

medicine.medical_specialtyRed Cellbusiness.industryMEDLINE030204 cardiovascular system & hematologyFibrinogenBlood cell03 medical and health sciences0302 clinical medicineAnesthesiology and Pain Medicinemedicine.anatomical_structureBlood productCryoprecipitatemedicinePlatelet030212 general & internal medicineFresh frozen plasmaIntensive care medicinebusinessmedicine.drugCurrent Opinion in Anaesthesiology
researchProduct

Rapid hemodilution induced by desmopressin after erythropoietin administration in humans

2011

We have shown that treatment with desmopressin has a very effective hemodilution effect in healthy humans. These results led us to suggest the possible role of desmopressin to mask blood doping in sports. Based on our results, the World Anti-Doping Agency included the desmopressin in the 2011 List of Prohibited Substances and Methods. On this occasion, the aim of our study was to test the desmopressin-induced hemodilution after rHuEpo administration in humans. This was an intra-subject, crossover study in which five physically active males acted as their own controls. A basal blood sample was taken on their first visit to the laboratory. The next day, the subjects began the treatment. They …

medicine.medical_specialtyReticulocytesPLASMA VOLUME EXPANDERS[SDV]Life Sciences [q-bio]Physical Therapy Sports Therapy and RehabilitationHematocrit01 natural sciences03 medical and health sciences0302 clinical medicineBlood dopingInternal medicinemedicineEducación Física y DeportivaHaematocritHemoglobinSTIMULATION INDEXlcsh:Sports medicineDesmopressinHEMOGLOBINmedicine.diagnostic_testbusiness.industry010401 analytical chemistryPlasma volume expanders030229 sport sciencesCrossover study3. Good health0104 chemical sciencesStimulation index and plasma volume expandersEndocrinologyBasal (medicine)HematocritErythropoietinAnesthesiaHemoglobinHEMATOCRITHaemoglobinbusinesslcsh:RC1200-1245hormones hormone substitutes and hormone antagonistsmedicine.drugJournal of Human Sport and Exercise
researchProduct

VIPoma and PPoma

2015

Gastrinomas are rare tumors of the neuroendocrine system, occurring within the pancreas and duodenum. The annual incidence is estimated at 0.5 per million of the population [1]. Overproduction of gastrin by these tumors produces a sustained increase in gastric acid secretion, leading to clinical manifestations of complicated peptic ulcer disease known as the Zollinger-Ellison syndrome (ZES) [2]. Although most gastrinomas grow slowly, over 60 % are malignant and 25 % show rapid aggressive behavior [3-5]. Most commonly gastrinomas metastasize to regional lymph nodes and the liver, and it is this malignant potential which has become increasingly important since the introduction of effective me…

medicine.medical_specialtySettore MED/06 - Oncologia Medicabusiness.industryMedicine (all)Vasoactive intestinal peptidePlasma levelsmedicine.diseaseMalignancyGastroenterologyIslet cell tumourInternal medicineWatery diarrhoeaMedicinePancreatic polypeptideSecretionHuman medicinebusinessVIPoma
researchProduct